Prosecution Insights
Last updated: October 04, 2026

Dna Genotek Inc.

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Dna Genotek Inc. is currently navigating 4 pending office actions within the Medical Devices & Mechanical Engineering technology area. These matters are distributed across 4 distinct examiners, indicating a wide distribution of individual examiner interactions for the company. This spread shows that multiple examiners are simultaneously reviewing the company's active cases, with each examiner responsible for a portion of the 4 pending office actions.

The prosecution activity is organized across 2 distinct art units, suggesting that the company's Medical Devices & Mechanical Engineering filings are concentrated in specific technical subgroups. The busiest examiner, FARDANESH, MARJAN, is currently handling 1 busiest examiner pending action. With 4 distinct examiners involved, the company must manage relationships across 2 distinct art units to resolve its current prosecution matters. This decentralized examiner approach across 2 distinct art units requires a coordinated strategy to maintain consistency across the 1 busiest examiner pending action and other matters in the portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
3
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (25%)
Multi-statute (no §101)3 (75%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
25% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
50% of docket
1
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FARDANESH, MARJAN 1 72.6% +18.9%
HEALY, NOAH MICHAEL 1 57.8% +34.8%
ALABI, OYELEYE A 1 84.0% +25.2%
MOSS, NATALIE M 1 30.8% +17.1%

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17995138 STABILIZING COMPOSITION AND METHOD FOR PRESERVING A BODILY FLUID MOSS, NATALIE M 29d
18869050 LIQUID SAMPLER FOR FAST CAPTURE OF INITIAL VOLUME OF A LIQUID FLOW FARDANESH, MARJAN —
18865083 BIOLOGICAL SAMPLE COLLECTION SYSTEM WITH PUSH-ACTIVATED VALVE FOR SAMPLE RELEASE HEALY, NOAH MICHAEL —
18568538 LOW PH COMPOSITION AND METHOD FOR STABILIZING NUCLEIC ACIDS IN BIOLOGICAL SAMPLES ALABI, OYELEYE A —

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17995138 STABILIZING COMPOSITION AND METHOD FOR PRESERVING A BODILY FLUID MOSS, NATALIE M 29d
18869050 LIQUID SAMPLER FOR FAST CAPTURE OF INITIAL VOLUME OF A LIQUID FLOW FARDANESH, MARJAN —
18865083 BIOLOGICAL SAMPLE COLLECTION SYSTEM WITH PUSH-ACTIVATED VALVE FOR SAMPLE RELEASE HEALY, NOAH MICHAEL —
18568538 LOW PH COMPOSITION AND METHOD FOR STABILIZING NUCLEIC ACIDS IN BIOLOGICAL SAMPLES ALABI, OYELEYE A —

Top Art Units

Art UnitApps
3791 2
1653 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18869050 LIQUID SAMPLER FOR FAST CAPTURE OF INITIAL VOLUME OF A LIQUID FLOW FARDANESH, MARJAN 3791 §102§112 Non-Final OA — Pending Nov 25, 2024
18865083 BIOLOGICAL SAMPLE COLLECTION SYSTEM WITH PUSH-ACTIVATED VALVE FOR SAMPLE RELEASE HEALY, NOAH MICHAEL 3791 §102§103 Non-Final OA — Pending Nov 12, 2024
18568538 LOW PH COMPOSITION AND METHOD FOR STABILIZING NUCLEIC ACIDS IN BIOLOGICAL SAMPLES ALABI, OYELEYE A — §102§103 Non-Final OA — Pending Dec 08, 2023
17995138 STABILIZING COMPOSITION AND METHOD FOR PRESERVING A BODILY FLUID MOSS, NATALIE M 1653 §101§103§112 Final Rejection 29d Pending Sep 30, 2022

Managing Dna Genotek Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month